Work during the past two decades has highlighted how HIV contributes to hepatic inflammation and fibrosis, leading to changes in the timing of antiretroviral therapy initiation and to improved diagnosis and management of liver disease in patients with HIV. As this population ages, clinician vigilance with early detection of emerging liver disease will be critical.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Benhamou, Y. et al. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group. Hepatology 30, 1054–1058 (1999).
Puoti, M. et al. Natural history of chronic hepatitis B in co-infected patients. J. Hepatol. 44, S65–S70 (2006).
Tuyama, A. C. et al. Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV/hepatitis C virus-induced liver fibrosis. Hepatology 52, 612–622 (2010).
Weber, R. et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch. Intern. Med. 166, 1632–1641 (2006).
INSIGHT START Study Group. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N. Engl. J. Med. 373, 795–807 (2015).
Brenchley, J. M. et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 12, 1365–1371 (2006).
Wallet, M. A. et al. Microbial translocation induces persistent macrophage activation unrelated to HIV-1 levels or T cell activation following therapy. AIDS 24, 1281–1290 (2010).
Mosoian, A. et al. Frontline science: HIV infection of Kupffer cells results in an amplified proinflammatory response to LPS. J. Leukoc. Biol. 101, 1083–1090 (2017).
Balagopal, A. et al. Human immunodeficiency virus-related microbial translocation and progression of hepatitis C. Gastroenterology 135, 226–233 (2008).
Lemoine, M., Serfaty, L. & Capeau, J. From nonalcoholic fatty liver to nonalcoholic steatohepatitis and cirrhosis in HIV-infected patients: diagnosis and management. Curr. Opin. Infect. Dis. 25, 10–16 (2012).
Acknowledgements
M.B.B. is supported by the NIH grant 5R01DK108364.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Chamroonkul, N., Bansal, M.B. HIV and the liver. Nat Rev Gastroenterol Hepatol 16, 1–2 (2019). https://doi.org/10.1038/s41575-018-0085-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41575-018-0085-7
This article is cited by
-
Infections at the nexus of metabolic-associated fatty liver disease
Archives of Toxicology (2021)